Statin activation of skeletal ryanodine receptors (RyR1) is a class effect but separable from HMG-CoA reductase inhibition.
Saved in:
| Title: | Statin activation of skeletal ryanodine receptors (RyR1) is a class effect but separable from HMG-CoA reductase inhibition. |
|---|---|
| Authors: | Lindsay C; Department of Pharmacology, University of Oxford, Oxford, UK., Musgaard M; Structural Bioinformatics and Computational Biochemistry, Department of Biochemistry, University of Oxford, Oxford, UK.; OMass Therapeutics, Oxford, UK., Russell AJ; Department of Pharmacology, University of Oxford, Oxford, UK.; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK., Sitsapesan R; Department of Pharmacology, University of Oxford, Oxford, UK. |
| Source: | British journal of pharmacology [Br J Pharmacol] 2022 Nov; Vol. 179 (21), pp. 4941-4957. Date of Electronic Publication: 2022 Aug 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1476-5381 |
|---|---|
| DOI: | 10.1111/bph.15893 |
